David L. Crowe - Concepedia

Author

David L. Crowe

Also Known As

Crowe, David, D Crowe, D L Crowe, D. Crowe, D. L. Crowe, D.L Crowe, D.L. Crowe, DAVID L CROWE, DAVID L. CROWE, David Crowe

116

Publications

2.7K

Citations

H-Index

Concepts

All Affiliations

University of Southern California University of Illinois Chicago Southern California University for Professional Studies Children's Hospital of Los Angeles Harvard University

About

David L. Crowe is an author at University of Southern California specializing in medicine, cell biology, and tumor biology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	22	36	1.6K
2	Health Sciences	7	7	174
3	Natural Sciences	3	3	269
4	Education	1	1	26
5	Engineering	1	1	27

David L. Crowe

Publications

2.4K

Citations

H-Index

Page 1

	Year	Citations
Conserved function of mSpry-2, a murine homolog of Drosophila sprouty, which negatively modulates respiratory organogenesis J.Denise Tefft, Matt Lee, Susan M. Smith, Current Biology BiologyConserved FunctionDevelopmental BiologyMurine HomologDevelopmental Genetics	1999	233
Abnormal expression of retinoic acid receptors and keratin 19 by human oral and epidermal squamous cell carcinoma cell lines. Lan Hu, David L. Crowe, James G. Rheinwald, PubMed Retinoic Acid ReceptorRetinoic AcidDermatologyTumor BiologyOral Cancer	1991	208
E2F-1 represses transcription of the human telomerase reverse transcriptase gene David L. Crowe Nucleic Acids Research GeneticsTelomerase ActivityGenomic MechanismMolecular GeneticsCancer Biology	2001	132
mSprouty2 inhibits FGF10-activated MAP kinase by differentially binding to upstream target proteins Denise Tefft, M. Lee, Susan M. Smith, American Journal of Physiology-Lung Cellular and Molecular Physiology	2002	115
A retinoid X receptor (RXR)-selective retinoid reveals that RXR-α is potentially a therapeutic target in breast cancer cell lines, and that it potentiates antiproliferative and apoptotic responses to peroxisome proliferator-activated receptor ligands David L. Crowe, Roshantha A.S. Chandraratna Breast Cancer Research	2004	99
EphB4 provides survival advantage to squamous cell carcinoma of the head and neck Rizwan Masood, Sunil Kumar, Uttam K. Sinha, International Journal of Cancer Squamous Cell CarcinomaImmunologyPathologyCancer BiologyTreatment Resistance	2006	80
Expression of myogenic regulatory factors during the development of mouse tongue striated muscle Akira Yamane, Mark Mayo, Charles F. Shuler, Archives of Oral Biology Muscle FunctionDevelopmental BiologySkeletal MuscleMouse TonguePhysiology	2000	68
Hypoxic induction of HIF-1α and VEGF expression in head and neck squamous cell carcinoma lines is mediated by stress activated protein kinases Babak Shemirani, David L. Crowe Oral Oncology Tumor BiologyMedicineProtein KinasesPathologyVegf Expression	2002	66
Proteomic based identification of manganese superoxide dismutase 2 (SOD2) as a metastasis marker for oral squamous cell carcinoma. Hui Ye, Anxun Wang, Bao-Shiang Lee, PubMed PathologyMetastasis MarkerCancer BiologyRedox BiologyTumor Biology	2008	63
Keratin 19 Downregulation by Oral Squamous Cell Carcinoma Lines Increases Invasive Potential David L. Crowe, G. E. Milo, C. E. Shuler Journal of Dental Research Squamous Cell CarcinomaPathologyKeratin Intermediate FilamentsDermatologyCancer Biology	1999	61

Page 1